Patent · US Active

CD1a antibodies and uses thereof

US11746154B2 · kind B2 · utility

0Cited by

3References

53Claims

0Family size

Assignees

PFIZER INC. · US
Children's Medical Center Corporation · US

Inventors

Florian WINAU · Boston, US
Oleg Kovalenko · Cambridge, US
Chew-Shun Chang · Gaithersburg, US
Di Wu · Danbury, US
Nicholas Andrew MARZE · Quincy, US
Shian-Huey Chiang · Cary, US

Key dates

Filing date	Oct 7, 2021
Grant date	Sep 5, 2023
Priority date	—
Expiry date	Oct 7, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibodies, and antigen-binding fragments thereof, that specifically bind to Cluster of Differentiation 1a (CD1a) are provided. Embodiments include uses, and associated methods of using the antibodies, and antigen-binding fragments thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.